Skip to main content

Covovax gets DCGI’s EUA nod for 12-17-year-olds

In a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in 12-17 year olds. This is the fourth vaccine to get regulatory approval for use in youngsters.

from Times of India https://ift.tt/6RltxIv
via
Labels:

Comments

Post a Comment

Popular posts from this blog

Wet spell likely in north & central India till Jan 9: IMD

The India Meteorological Department (IMD) on Wednesday predicted a wet spell over northwest India, including Delhi-NCR, Punjab and Haryana, and central India till January 9 due to two consecutive active western disturbances. It, however, said that there may not be cold wave conditions over north India during the next five days. from Times of India https://ift.tt/34pJ29g via
Post a Comment
Read more

Kashmiri Pandit killed in J&K's Shopian, 7th since 2020

A terrorist shot dead 43-year-old Kashmiri Pandit farmer Puran Krishan Bhat outside his home in Choudharygund village of south Kashmir’s Shopian district Saturday morning, triggering protests in Jammu against the latest targeted attack on the community. DIG Sujit Kumar said Kashmir Freedom Fighter (KFF), the proxy name of a terrorist outfit, claimed responsibility for the attack on Bhat. from Times of India https://ift.tt/Sk9sv5q via
Post a Comment
Read more

Molnupiravir has serious safety concerns: ICMR chief

Antiviral drug molnupiravir, which recently got approval from the drug regulator and is being launched by several local drug makers, has serious safety concerns, and thus has not been included in the national Covid-19 clinical protocol recommended by the health ministry, the Indian Council of Medical Research (ICMR) director general Balram Bhargava said. from Times of India https://ift.tt/3pXmODT via
Post a Comment
Read more